Making Cancer History®: Free seminar comes to Raleigh
The University of Texas MD Anderson Cancer Center brings its signature Making Cancer History® seminar to Raleigh, N.C., for the first...

MorphoSys, MD Anderson join forces to develop novel...
MorphoSys AG and The University of Texas MD Anderson Cancer Center today announced a long-term strategic alliance for the discovery...
MD Anderson study uncovers early genetic changes in...
Researchers at The University of Texas MD Anderson Cancer Center have discovered mutations that may fuel early cancer growth in...
MD Anderson and Ionis Pharmaceuticals form strategic alliance to...
Ionis Pharmaceuticals, Inc.,and The University of Texas MD Anderson Cancer Center today announced the formation of a strategic...

MD Anderson receives $10.6 million from CPRIT for lung...
The University of Texas MD Anderson Cancer Center will receive $10.6 million in funding from the Cancer Prevention and Research...
Strike out cancer and celebrate survivorship at the ballpark
A double-header of cancer prevention and Chihuahuas baseball is in store for El Pasoans as experts from The University of Texas MD...
Study shows possible ‘key’ to improved therapy for...
A study comprised of 39 international institutions revealed significant new findings about adrenocortical carcinoma (ACC), a rare...
Can gender play a role in determining cancer treatment...
It is well known that men and women differ in terms of cancer susceptibility, survival and mortality, but exactly why this occurs at a...
MD Anderson applauds extension of FDA regulatory authority...
The University of Texas MD Anderson Cancer Center fully supports new rules issued by the Food and Drug Administration (FDA) today to...
Study points to therapeutic target for common and...
Small, non-coding molecules called microRNAs are known to play an important role in cancer development. Researchers now have shown...
Research findings reveal potential to reverse...
A study providing new information about neuropathic pain afflicting some 90 percent of cancer patients who have had nerve damage...